238 related articles for article (PubMed ID: 22545122)
21. Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression.
Michaelis M; Rothweiler F; Nerreter T; van Rikxoort M; Zehner R; Dirks WG; Wiese M; Cinatl J
BMC Res Notes; 2014 Oct; 7():710. PubMed ID: 25300205
[TBL] [Abstract][Full Text] [Related]
22. Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance.
Kaliszczak M; Patel H; Kroll SH; Carroll L; Smith G; Delaney S; Heathcote DA; Bondke A; Fuchter MJ; Coombes RC; Barrett AG; Ali S; Aboagye EO
Br J Cancer; 2013 Oct; 109(9):2356-67. PubMed ID: 24071597
[TBL] [Abstract][Full Text] [Related]
23. Karanjin interferes with ABCB1, ABCC1, and ABCG2.
Michaelis M; Rothweiler F; Nerreter T; Sharifi M; Ghafourian T; Cinatl J
J Pharm Pharm Sci; 2014; 17(1):92-105. PubMed ID: 24735762
[TBL] [Abstract][Full Text] [Related]
24. Rapid detection of ABC transporter interaction: potential utility in pharmacology.
Robey RW; Lin B; Qiu J; Chan LL; Bates SE
J Pharmacol Toxicol Methods; 2011; 63(3):217-22. PubMed ID: 21112407
[TBL] [Abstract][Full Text] [Related]
25. Temporal/spatial expression and efflux activity of ABC transporter, P-glycoprotein/Abcb1 isoforms and Bcrp/Abcg2 during early murine development.
Sawicki WT; Kujawa M; Jankowska-Steifer E; Mystkowska ET; Hyc A; Kowalewski C
Gene Expr Patterns; 2006 Oct; 6(7):738-46. PubMed ID: 16458078
[TBL] [Abstract][Full Text] [Related]
26. Nilotinib enhances the efficacy of conventional chemotherapeutic drugs in CD34⁺CD38⁻ stem cells and ABC transporter overexpressing leukemia cells.
Wang F; Wang XK; Shi CJ; Zhang H; Hu YP; Chen YF; Fu LW
Molecules; 2014 Mar; 19(3):3356-75. PubMed ID: 24651611
[TBL] [Abstract][Full Text] [Related]
27. Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance modulator through the inhibition of ABCC1 transporter.
Vagiannis D; Zhang Y; Budagaga Y; Novotna E; Skarka A; Kammerer S; Küpper JH; Hofman J
Toxicol Appl Pharmacol; 2022 Jan; 434():115823. PubMed ID: 34896433
[TBL] [Abstract][Full Text] [Related]
28. Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells.
Shukla S; Schwartz C; Kapoor K; Kouanda A; Ambudkar SV
Drug Metab Dispos; 2012 Feb; 40(2):304-12. PubMed ID: 22041108
[TBL] [Abstract][Full Text] [Related]
29. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
Shukla S; Robey RW; Bates SE; Ambudkar SV
Drug Metab Dispos; 2009 Feb; 37(2):359-65. PubMed ID: 18971320
[TBL] [Abstract][Full Text] [Related]
30. Expression of ABC transporters is an unfavorable prognostic factor in laryngeal squamous cell carcinoma.
Shen B; Li D; Dong P; Gao S
Ann Otol Rhinol Laryngol; 2011 Dec; 120(12):820-7. PubMed ID: 22279954
[TBL] [Abstract][Full Text] [Related]
31. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.
Vesel M; Rapp J; Feller D; Kiss E; Jaromi L; Meggyes M; Miskei G; Duga B; Smuk G; Laszlo T; Karner I; Pongracz JE
Respir Res; 2017 Mar; 18(1):52. PubMed ID: 28340578
[TBL] [Abstract][Full Text] [Related]
32. Revisiting the role of ABC transporters in multidrug-resistant cancer.
Robey RW; Pluchino KM; Hall MD; Fojo AT; Bates SE; Gottesman MM
Nat Rev Cancer; 2018 Jul; 18(7):452-464. PubMed ID: 29643473
[TBL] [Abstract][Full Text] [Related]
33. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.
Römermann K; Wanek T; Bankstahl M; Bankstahl JP; Fedrowitz M; Müller M; Löscher W; Kuntner C; Langer O
Nucl Med Biol; 2013 Oct; 40(7):873-8. PubMed ID: 23845421
[TBL] [Abstract][Full Text] [Related]
34. Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro.
Cihalova D; Ceckova M; Kucera R; Klimes J; Staud F
Biochem Pharmacol; 2015 Dec; 98(3):465-72. PubMed ID: 26300056
[TBL] [Abstract][Full Text] [Related]
35. Expression and function of multidrug resistance transporters at the blood-brain barriers.
Scherrmann JM
Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):233-46. PubMed ID: 16922639
[TBL] [Abstract][Full Text] [Related]
36. Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1.
Wang YJ; Kathawala RJ; Zhang YK; Patel A; Kumar P; Shukla S; Fung KL; Ambudkar SV; Talele TT; Chen ZS
Biochem Pharmacol; 2014 Aug; 90(4):367-78. PubMed ID: 24937702
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis of candidate ABC transporter proteins for sitosterol transport.
Albrecht C; Elliott JI; Sardini A; Litman T; Stieger B; Meier PJ; Higgins CF
Biochim Biophys Acta; 2002 Dec; 1567(1-2):133-42. PubMed ID: 12488046
[TBL] [Abstract][Full Text] [Related]
38. Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp.
Zhang Y; Laterra J; Pomper MG
Neoplasia; 2009 Jan; 11(1):96-101. PubMed ID: 19107236
[TBL] [Abstract][Full Text] [Related]
39. Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.
Dai CL; Liang YJ; Chen LM; Zhang X; Deng WJ; Su XD; Shi Z; Wu CP; Ashby CR; Akiyama S; Ambudkar SV; Chen ZS; Fu LW
Biochem Pharmacol; 2009 Aug; 78(4):355-64. PubMed ID: 19410561
[TBL] [Abstract][Full Text] [Related]
40. Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells.
Shubbar MH; Penny JI
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2314-2322. PubMed ID: 30048740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
